SINOVA-M-14026 Thyroxine (T4) Quantitative Test Kit

Clinical Significance:
Increased Levels:
Hyperthyroidism: Painless thyroiditis, subacute thyroiditis, exophthalmic hyperthyroidism, thyroid medication intake, teratoma, malignant choriocarcinoma, pituitary thyrotropin-secreting tumor.
Normal Thyroid Function: Increased TBG (thyroid-binding globulin) (familial), pregnancy, newborns, some liver cancers, acute hepatitis, acute intermittent porphyria, medications (steroids, contraceptives), positive anti-thyroxine antibodies in chronic thyroiditis, familial dysalbuminemic hyperthyroxinemia, excessive TBPA (thyroxine-binding prealbumin), transient hyperthyroxinemia (acute illness, oral cholecystography agents).
Decreased Levels:
Hypothyroidism: Chronic thyroiditis, cretinism, iodine organification defects, pituitary hypothyroidism.
Normal Thyroid Function: Decreased TBG (familial), nephrotic syndrome, dialysis treatment, hypoproteinemia, protein-losing enteropathy, liver cirrhosis, medications (testosterone, anabolic steroids, corticosteroids, salicylates, phenytoin, carbamazepine, heparin).
Low T3 Syndrome: Severe illness, excessive T3 intake.
T4-Type Hyperthyroidism: Elevated T4 with normal T3.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing and monitoring thyroid disorders, including hyperthyroidism, hypothyroidism, and low T3 syndrome.
Endocrinology Departments: To assess thyroid function and manage conditions with altered thyroid hormone levels, such as thyroiditis, thyroid tumors, and medication effects on thyroid function.
Diagnostic Laboratories: For routine thyroid function testing, especially in cases of suspected thyroid hormone imbalances.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc.
Global Health Programs: International health initiatives focusing on improving thyroid health and managing endocrine disorders in low-resource settings.